Team:UB Indonesia

From 2014.igem.org

(Difference between revisions)
 
(40 intermediate revisions not shown)
Line 99: Line 99:
<a href="#background" class="fancybox"><p><i class="icon icon-desktop"></i></p></a>
<a href="#background" class="fancybox"><p><i class="icon icon-desktop"></i></p></a>
<div id="background" style="display:none;width:700px;">
<div id="background" style="display:none;width:700px;">
-
<h2><center>“A BETTER FUTURE WITH SYNTHETIC BIOLOGY”</center></h2>
+
<h2><center>A BETTER FUTURE WITH SYNTHETIC BIOLOGY</center></h2>
<p align="justify">Study of synthetic biology emerged as a multidisciplinary science that help people in solving various problems. Among the general public, synthetic biology is famous as bioengineering and extreme genetic engineering which have an advantage in redesigning a life through genetical circuit, thus allows people to manipulate a new organism for use in treatment and diagnosis of disease, provision of quality seeds, remediation of environmental pollution caused by industrial and mining as well as the mitigation of global warming. <br><br>
<p align="justify">Study of synthetic biology emerged as a multidisciplinary science that help people in solving various problems. Among the general public, synthetic biology is famous as bioengineering and extreme genetic engineering which have an advantage in redesigning a life through genetical circuit, thus allows people to manipulate a new organism for use in treatment and diagnosis of disease, provision of quality seeds, remediation of environmental pollution caused by industrial and mining as well as the mitigation of global warming. <br><br>
Indonesia as one of the currently high development countries in science is allowing for synthetic biology to grow rapidly. Prospects for the synthetic biology's development in Indonesia, among others, is the independence of technology in the health sector include the development of a specific diagnosis, the provision of pharmaceutical raw materials, and technology screening for Indonesia natural resources which have potency to treat various types of diseases.<br><br>
Indonesia as one of the currently high development countries in science is allowing for synthetic biology to grow rapidly. Prospects for the synthetic biology's development in Indonesia, among others, is the independence of technology in the health sector include the development of a specific diagnosis, the provision of pharmaceutical raw materials, and technology screening for Indonesia natural resources which have potency to treat various types of diseases.<br><br>
-
Brawijaya University iGEM team will develop synthetic biology in order to solve health sector problems, focus in Cervical Cancer. We have three sub-projects, they are: plant engineering for cervical cancer prevention, developing Cervical Cancer Care Program application for smartphone as helpdesk, and scanning technology for natural materials treatment (SCT Kit).</p>
+
Brawijaya University iGEM team will develop synthetic biology in order to solve health sector problems, focus in Cervical Cancer. We have three sub-projects, they are: plant engineering for cervical cancer prevention, developing Cervical Cancer Care Program application for smartphone as helpdesk, and scanning technology for natural materials treatment (CHS Kit).</p>
</div>
</div>
Line 112: Line 112:
<a href="#overview" class="fancybox"><p><i class="icon icon-eye-open"></i></p></a>
<a href="#overview" class="fancybox"><p><i class="icon icon-eye-open"></i></p></a>
                                         <div id="overview" style="display:none;width:700px;">
                                         <div id="overview" style="display:none;width:700px;">
-
<h2><center>“UB_INDONESIA BRINGS C3P (CERVICAL CANCER PROGRAM)</center></h2>
+
<h2><center>UB_INDONESIA BRINGS C3P (CERVICAL CANCER PROGRAM)</center></h2>
<p align="justify">
<p align="justify">
Cervical cancer is the second most common cancer in women worldwide. Yet, because of poor access to screening and treatment services, the number of deaths occur in women increase highly, especially in our country, Indonesia. Effective methods for early detection of precancerous lesions using cytology (Pap smear) exist, but not effective enough for detection in all age. However, new technological developments, using synthetic biology, offer the potential to tackle cervical cancer in a more comprehensive way and build a healthier future for girls and women. Here we go with our great idea!<br><br>
Cervical cancer is the second most common cancer in women worldwide. Yet, because of poor access to screening and treatment services, the number of deaths occur in women increase highly, especially in our country, Indonesia. Effective methods for early detection of precancerous lesions using cytology (Pap smear) exist, but not effective enough for detection in all age. However, new technological developments, using synthetic biology, offer the potential to tackle cervical cancer in a more comprehensive way and build a healthier future for girls and women. Here we go with our great idea!<br><br>
Line 118: Line 118:
We try to make an idea to build a new prototype for early detection to cervical cancer, especially caused by HPV 18 and HPV 16. We construct a new specific TALEs that can bind to our target sequences and we called it TALE 1 and TALE 2. In order to make sure the presence of DNA  from HPV 16 and 18, we need reporter which connect to detector.  Fluorescent protein usually used as reporter gene to study about gene expression. It will be connected to detector using linker. When the HPV DNA is bind to detector, blue colour will appear in the second strip. The Intensity of colour will be detected in our software and we can determined the risk level of cervical cancer disease. Dark blue colour show that the amount of  DNA  from HPV 16 and 18 is high and indicate the patient get severe cervical cancer.<br><br>
We try to make an idea to build a new prototype for early detection to cervical cancer, especially caused by HPV 18 and HPV 16. We construct a new specific TALEs that can bind to our target sequences and we called it TALE 1 and TALE 2. In order to make sure the presence of DNA  from HPV 16 and 18, we need reporter which connect to detector.  Fluorescent protein usually used as reporter gene to study about gene expression. It will be connected to detector using linker. When the HPV DNA is bind to detector, blue colour will appear in the second strip. The Intensity of colour will be detected in our software and we can determined the risk level of cervical cancer disease. Dark blue colour show that the amount of  DNA  from HPV 16 and 18 is high and indicate the patient get severe cervical cancer.<br><br>
Beside that, we try to take the advantage of tea plant. Tea plant (Camelia sinensis) has catechin compounds that contains antioxidants.  Catechin family that most effective used as antioxidant is Epigallocathecin gallate (EGCG).  Based on research in vitro or in silico, EGCG is able to inhibit the proliferation of cancer cells because stop over-expression between L1 HPV 16- EGFR (Epithel Growth Factor Receptor) bond but there are few of EGCG content in tea plant. Based on these problems, we would to over- expression EGCG by knockdown non-compound EGCG gene, so hopefully the content of EGCG on tea are more prominent.<br><br>
Beside that, we try to take the advantage of tea plant. Tea plant (Camelia sinensis) has catechin compounds that contains antioxidants.  Catechin family that most effective used as antioxidant is Epigallocathecin gallate (EGCG).  Based on research in vitro or in silico, EGCG is able to inhibit the proliferation of cancer cells because stop over-expression between L1 HPV 16- EGFR (Epithel Growth Factor Receptor) bond but there are few of EGCG content in tea plant. Based on these problems, we would to over- expression EGCG by knockdown non-compound EGCG gene, so hopefully the content of EGCG on tea are more prominent.<br><br>
-
SCT (screening Cancer Therapy) is a kit which contains of hela cells as cervical cancer cells and it was designed to screening the plants that have compund potentially for cervical cancer therapy. Herbs that potentially as a therapy of cervical cancer in the kit are marked by the absence of green or red colors, while the negative results are marked by the emergence of green or red in the kit. The kit is expected to provide convenience to the researchers in the field of cervical cancer and cervical cancer effects can be mitigated with natural compound that not a lot of side effects. <br><br>
+
CHS (Cancer Herbal Screening) is a kit which contains of hela cells as cervical cancer cells and it was designed to screening the plants that have compund potentially for cervical cancer therapy. Herbs that potentially as a therapy of cervical cancer in the kit are marked by the absence of green color, while the negative results are marked by the emergence of green in the kit. The kit is expected to provide convenience to the researchers in the field of cervical cancer and cervical cancer effects can be mitigated with natural compound that not a lot of side effects. <br><br>
From all of above, we bring C3P (Cervical Cancer Program) for iGEM 2014. We named our each project with preventing, screening and therapy. beside, we also do social action in other to socialize our project and be closer to society to inform them how to avoid cervical cancer. <br><br>
From all of above, we bring C3P (Cervical Cancer Program) for iGEM 2014. We named our each project with preventing, screening and therapy. beside, we also do social action in other to socialize our project and be closer to society to inform them how to avoid cervical cancer. <br><br>
The responsible of the scientist is not only the result in the lab, but also share “the right thing” for society. So, thanks to iGEM that gives us an opportunity for doing both, research and social action. <br><br>
The responsible of the scientist is not only the result in the lab, but also share “the right thing” for society. So, thanks to iGEM that gives us an opportunity for doing both, research and social action. <br><br>
Line 126: Line 126:
<h2 class="font-thin"><font color="#fff">Overview</font></h2>
<h2 class="font-thin"><font color="#fff">Overview</font></h2>
</div><!-- /col12 -->
</div><!-- /col12 -->
 +
 +
<div class="col-12 col-lg-4 col-sm-6">
 +
<a href="#achievement" class="fancybox"><p><i class="icon icon-trophy"></i></p></a>
 +
                                        <div id="achievement" style="display:none;width:700px;">
 +
<center>
 +
<table border="1">
 +
<tr>
 +
<td rowspan="5"><center><img src="https://static.igem.org/mediawiki/2013/7/78/PB_bronzeMedal.gif" width="150" height="200"><br>BRONZE MEDAL</center></td>
 +
<td>Register for iGEM and attend the Giant Jamboree</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="" height=""></td>
 +
</tr>
 +
<tr>
 +
<td>Create team wiki</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="" height=""></td>
 +
</tr>
 +
<tr>
 +
<td>Present a poster and talk at the Giant Jamboree</td><td><img src="https://static.igem.org/mediawiki/2014/6/66/UB-Progress.PNG" width="52" height="43"></td>
 +
</tr>
 +
<tr>
 +
<td>Art and design for synthetic biology</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="" height=""></td>
 +
</tr>
 +
<tr>
 +
<td>Demonstrate the active engagement of Engineers, Scientists, member of the public and other stakeholder (sponsor)</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="" height=""></td>
 +
</tr>
 +
</table>                                       
 +
 +
 +
<table border="1">
 +
<tr>
 +
<td rowspan="5"><center><img src="https://static.igem.org/mediawiki/2013/f/f0/PB_silverMedal.gif" width="150" height="200"><br>SILVER MEDAL</center></td>
 +
<td>Bronze requirement</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="" height=""></td>
 +
</tr>
 +
<tr>
 +
<td>Create a short film about or as part at the project and video must be sent to the comitte and iGEM Headquarter</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="" height=""></td>
 +
</tr>
 +
<tr>
 +
<td>Design and execute a workshop or event for a group of people outside the team</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="" height=""></td>
 +
</tr>
 +
<tr>
 +
<td>Produce an installation or experiment (contact art design @igem.org to arrange space for presently your project before October 1st</td><td><img src="https://static.igem.org/mediawiki/2014/f/f3/UB-Silang.PNG" width="52" height="43"></td>
 +
</tr>
 +
</table>                                       
 +
 +
 +
<table border="1">
 +
<tr>
 +
<td rowspan="5"><center><img src="https://static.igem.org/mediawiki/2013/b/b0/PB_goldMedal.gif" width="150" height="200"><br>GOLD MEDAL</center></td>
 +
<td>Bronze and silver requirement</td><td><img src="https://static.igem.org/mediawiki/2014/6/66/UB-Progress.PNG" width="52" height="43"></td>
 +
</tr>
 +
<tr>
 +
<td>Provoke people to think about synthetic biology & its implication in a new & novel way</td><td><img src="https://static.igem.org/mediawiki/2014/6/66/UB-Progress.PNG" width="52" height="43"></td>
 +
</tr>
 +
<tr>
 +
<td>Collaborate directly with an iGEM team in another track</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="52" height="43"></td>
 +
</tr>
 +
<tr>
 +
<td>Design new part for iGEM biobrick</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="52" height="43"></td>
 +
</tr>
 +
<tr>
 +
<td>Human practice about the project</td><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="52" height="43"></td>
 +
</tr>
 +
</table>                                       
 +
</center><br><br>
 +
<b>Note:</b><br>
 +
<table>
 +
<tr><td><img src="https://static.igem.org/mediawiki/2014/9/9a/UB-Check.PNG" width="52" height="43"></td><td>=</td><td>Done</td></tr>
 +
<tr><td><img src="https://static.igem.org/mediawiki/2014/6/66/UB-Progress.PNG" width="52" height="43"></td><td>=</td><td>In Progress</td></tr>
 +
<tr><td><img src="https://static.igem.org/mediawiki/2014/f/f3/UB-Silang.PNG" width="52" height="43"></td><td>=</td><td>Not yet</td></tr>
 +
</table>                                       
 +
                                        </div>
 +
                                        <h2 class="font-thin"><font color="#fff">Achievement</font></h2>
 +
</div><!-- /col12 -->
 +
                               
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
                                         <a href="#preventing" class="fancybox"><p><i class="icon icon-shield"></i></p></a>
                                         <a href="#preventing" class="fancybox"><p><i class="icon icon-shield"></i></p></a>
                                         <div id="preventing" style="display:none;width:700px;">
                                         <div id="preventing" style="display:none;width:700px;">
-
<h2><center>“Prevent is Better than Cure”</center></h2>
+
<h2><center>Prevent is Better than Cure</center></h2>
-
<p align="justify">Indonesia is an agricultural country that most of their society works as farmer. One of commodity in Indonesia is tea plantation which is located in Malang (Brawijaya University takes place). Malang is resited at 440-667 (mdpl) altitude, one of the tourist destinations in East Java because of the potential of natural and climatic owned. Malang climate conditions during 2008 temperatures recorded ranging from 22.7 ° C to 25.1 ° C. While the maximum temperature reached 32.7 ° C and minimum temperature of 18.4 ° C. The average air humidity range 79% - 86%. With a maximum moisture content of 99% and a minimum at 40%. These conditions favor the development of the tea plant (Camellia sinensis). <br>
+
<p align="justify">Indonesia is an agricultural country that most of their society works as farmer. Malang is resite at 440-667 (mdpl) altitude, one of the tourist destinations in East Java because of the potential of natural and climatic owned. Malang climate conditions during 2008 temperatures recorded ranging from 22.7 ° C to 25.1 ° C. While the maximum temperature reached 32.7 ° C and minimum temperature of 18.4 ° C. The average air humidity range 79% - 86%. With a maximum moisture content of 99% and a minimum at 40%. These conditions favor the development of the tea plant (Camellia sinensis).</p> <br>
-
<center><img src="https://static.igem.org/mediawiki/2014/e/ed/UB-Tea.PNG" width="" height=""></center><br>
+
<center><img src="https://static.igem.org/mediawiki/2014/f/f8/UB-G1.jpg" height="300"><br>
 +
Figure 1. Tea Plantation in Lawang, Malang City (Department of Electrical Engineering Brawijaya University, 2014)</center><br>
-
Tea extract contain EGCG used as the most effective antioxidant to against cervical cancer. But, levels of EGCG (Epigallocathecin gallate) in tea is very slightly. So, we will increase the level of this EGCG compound using siRNA to knockdown gene non-EGCG with expectation it will produce high yield of antioxidant. The applications are for supplement or feminine hygiene.<br><br>
+
<p align="justify">Tea extract contain EGCG used as the most effective antioxidant to against cervical cancer. Epigallocatechin-3-gallate (EGCG) is a polyphenol constituent present in green tea to inhibit cancer growth and the effects of EGCG is a potential anti-proliferative and pro-apoptotic agent in the human ovarian cancer line.But, levels of EGCG (Epigallocathecin gallate) in tea is very slightly. So, we will increase the level of this EGCG compound using siRNA to knockdown gene non-EGCG with expectation it will produce high yield of antioxidant. The applications are for supplement or feminine hygiene.</p> <br>
 +
<center><table border="1" align="center">
 +
<tr>
 +
<td><center><img src="https://static.igem.org/mediawiki/2014/3/36/UB-EGCG_structure_2D.png" width="300" height="300"><br>Figure 2. EGCG structure 2D (National Center for Biotechnology Information, 2005)</center></td>
 +
<td><center><img src="https://static.igem.org/mediawiki/2014/e/e5/EGCG_structure_3D.png" width="300" height="300"><br>Figure 3. EGCG structure 3D (National Center for Biotechnology Information, 2005)</center></td>
 +
</tr>
 +
</table>
 +
</center>
 +
<br><br>
-
Tea plant (Camelia sinensis) has catechin compounds that contains antioxidants.  Catechin family that most effective used as antioxidant is Epigallocathecin gallate (EGCG).  Based on research in vitro or in silico, EGCG is able to inhibit the proliferation of cancer cells because stop over-expression between L1 HPV 16- EGFR (Epithel Growth Factor Receptor) bond but there are few of EGCG content in tea plant. Based on these problems, we would to over- expression EGCG by knockdown non-compound EGCG gene, so hopefully the content of EGCG on tea are more prominent. We design siRNA sequence from LAR gene (to inhibit non-EGCG compound) using bioinformatics tool and use P97 promoter to initiate expression in mammalian cell (using HeLa cell). That part will be insert into the psB1C3 linear backbone. To checking performance of this part, we insert sequence target of siRNA into the plasmid Bba_E0240 and get the promoter CMV from Bba_K747096 part. We also prepare for positive control and negative control for this experiment. Positive control part containing siRNA for GFP, insert into Bba_K747096 part that contain CMV promoter, and negative control containing CMV promoter and insert to the Bba_E0240 part containing GFP. Each part will be growth in HeLa cell culture and observed the succeding by fluorescent microscope.
+
<p align="justify">Tea plant (Camelia sinensis) has catechin compounds that contains antioxidants.  Catechin family that most effective used as antioxidant is Epigallocathecin gallate (EGCG).  Based on research in vitro and in silico, EGCG is able to inhibit the proliferation of cancer cells with stop over-expression between L1 HPV 16- EGFR (Epithel Growth Factor Receptor) bond but there are few of EGCG content in tea plant. Based on these problems, we would to over- expression EGCG by knockdown non-compound EGCG gene, so hopefully the content of EGCG on tea are more prominent.<br><br>
 +
 
 +
<b>Our Design</b><br>
 +
EGCG is able to inhibit the proliferation of cancer cells (Cornelia, 2013) because stop over-expression between L1 HPV 16- EGFR (Epithel Growth Factor Receptor) bond but there are few of EGCG content in tea plant. Based on these problems, we would to over- expression EGCG by knockdown non-compound EGCG gene, so hopefully the content of EGCG on tea are more prominent.<br><br>
 +
 
 +
We design siRNA sequence from LAR gene (to inhibit non-EGCG compound) using bioinformatics tool to initiate expression in mammalian cell (using HeLa cell). That part will be insert into the pSB1C3 linear backbone. To checking performance of this part, should be react with sequence target of siRNA LAR into the plasmid pSB1C3. We also prepare for positive control containing siRNA for GFP, insert into pSB1C3. Each part will be growth in HeLa cell culture and observed the succeding by fluorescent microscope.<br><br>
 +
 
 +
In this experiment, we design 2 part of biobrick:<br>
 +
1.  siRNA LAR (Bba_K1367004) gene insert in pSB1C3 plasmid backbone (plasmid A)<br>
 +
2.  siRNA GFP (Bba_K1367005) gene insert in pSB1C3 plasmid backbone (plasmid B)<br><br>
 +
 
 +
Plasmid A:
 +
</p><br>
 +
<center><img src="https://static.igem.org/mediawiki/2014/f/fc/UB-Plasmid_A.PNG" width="700px" height="300"><br>
 +
Figure 4 Construct design siRNA LAR BBa_K1367004 inserted in pSB1C3<br><br>
 +
</center>
 +
<p align="left">
 +
Plasmid A:
 +
</p><br>
 +
<center><img src="https://static.igem.org/mediawiki/2014/6/67/UB-Plasmid_B.PNG" width="700px" height="300"><br>
 +
Figure 5. Construct design siRNA GFP  BBa_K1367005 inserted in pSB1C3<br><br>
 +
</center>
 +
 
 +
<p align="justify">
 +
<b>References:</b><br>
 +
<ul>
 +
<li>Cornelia, Braicu, Gherman CD, Irimie A and Berindan-Neagoe I. 2013. Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells. J Nanosci Nanotechnol. Jan;13(1):632-7.</li>
 +
<li>Department of Electrical Engineering Brawijaya University. 2014. Tourism in Malang. http://eeccis.ub.ac.id/. Access at 10 October 2014</li>
 +
<li>National Center for Biotechnology Information. 2005. epigallocatechin gallate. http://pubchem.ncbi.nlm.nih.gov. Access at 10 October 2014.</li>
 +
</ul>
</p>
</p>
                                         </div>
                                         </div>
Line 144: Line 253:
                                         <a href="#screening" class="fancybox"><p><i class="icon icon-stethoscope"></i></p></a>
                                         <a href="#screening" class="fancybox"><p><i class="icon icon-stethoscope"></i></p></a>
                                         <div id="screening" style="display:none;width:700px;">
                                         <div id="screening" style="display:none;width:700px;">
-
<h2><center>“Cercival Cancer Screening Kit”</center></h2>
+
<h2><center>Cercival Cancer Screening Kit</center></h2>
<p align="justify">
<p align="justify">
<b>
<b>
Line 238: Line 347:
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Screening</font></h2>
<h2 class="font-thin"><font color="#fff">Screening</font></h2>
-
</div><!-- /col12 -->
 
-
<div class="col-12 col-lg-4 col-sm-6">
 
-
 
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
<a href="#therapy" class="fancybox"><p><i class="icon icon-medkit"></i></p></a>
<a href="#therapy" class="fancybox"><p><i class="icon icon-medkit"></i></p></a>
                                         <div id="therapy" style="display:none;width:700px;">
                                         <div id="therapy" style="display:none;width:700px;">
-
<h2><center>“SCT - Screening Cancer Therapy”</center></h2>
+
<h2><center>CHS - (Cancer Herbal Screening)</center></h2>
<p align="justify">
<p align="justify">
-
SCT (screening Cancer Therapy) is a kit which contains of hela cells as cervical cancer cells and it was designed to screening the plants that have compund potentially for cervical cancer therapy. The kit designed with plasmid that contain with HPV 16 or HPV 18 promoter. Each promoter to be accompained by two types of fluorescence reporter such as green (GFP) and red (RFP). The reporter compound obtained from biobrick. GFP obtained from Bba_E0240 (Plate 4, well 11N), then RFP obtained from Bba_K516132 (Plate 1, well 11A). Plasmid also designed with another compund such as RBS and double terminator. GFP act as a marker for the detection viruses whether plasmids have been inserted in hela cells and RFP as a marker for checking the ability of herbal compound used in the treatment of cervical cancer. <br><br>
+
<b>Overview Therapy</b><br>
-
Herbs that potentially as a therapy of cervical cancer in the kit are marked by the absence of green or red colors, while the negative results are marked by the emergence of green or red in the kit. The construct in the kit design is herbs can inhibit HPV promoter so that promoters cannot work anymore. The kit is expected to provide convenience to the researchers in the field of cervical cancer and cervical cancer effects can be mitigated with natural compound that not a lot of side effects.  
+
Cervical cancer is the one of most killing cause of woman. Approximately, 300.000 people deaths by cervical cancer in every year (Frazer, Cox et al., 2006; Lowy and Schiller, 2006).Cervical cancer caused by Human papillomaviruses (HPV) (Martinez et al., 2008).More than 100 types of HPVs have been identified to date (Dell et al., 2001), but the two most common types in cervical cancer are HPV 16 and 18. HPV type 16 and 18 are high risk type that causecervical cancer (Das, 2003). Both of those type responsible for approximately 70 % of all cases (Smith et al., 2007).<br><br>
 +
 
 +
HPV are small double-stranded DNA viruses that contain of two oncogenes E6 and E7 that are involved in cellular transformation. Two viral genes, E6 and E7 are commonly found expressed in these cancer cells (Song, 2000). Transcription of the human papillomavirus type 16 (HPV-16) genome is controlled by several promoters and the P97 promoter is considered to be the main one (Braunstein et al., 1999). P97 is the HPV-16 early promoter involved in the transcription of E6, E7 and other viral genes (Dell and Gaston, 2011; Flores and Lambert, 1997; Hebner and Laimins, 2006. Based on Laura et al (2005), P105 is located to the next E6 start codon and is the main early promoter of HPV-18. AP-1, Sp-1, NF-1, Oct-1, TEF-1, YY-1, KRF-1, Skn-1a, and TFIID known as transcription factors that could stimulate P105 promoter activity. HPV-18 P105 promoter and HPV-16 P97 promoter has equivalent function. E2 repression of P105 promoter activity has been demonstrated in HeLa cells (Thierry and Yaniv, 1987) and in primary human keratinocytes (Bernard et al., 1989). Romanczuk et al(1990), suggested that P97 and P105 promoters both could be regulated by similar mechanisms. A comparison of the sequences upstream of the HPV-16 P97 promoter and the HPV-18 P105 promoter revealed a similar spatial arrangement of the four E2-binding sites, the TATAAAA boxes, and the start sites for transcription in the respective viral LCRs. (Romanczuk et al, 1990).  Based on Chong et al(1991), trancript factor such as NF1, AP-1, and oct-1 were present in higher concentration in HeLa cells. Therefor, HeLa cells can be used as transfection for promoter P97 and promoter P105 so it could be activated.<br><br>
 +
 
 +
Indonesia has many potential herb that potentially used as medicine for cervical cancer.  The major goal ofthis research is to create a kit that can screen herb potentially used as medicine for cervical cancer. It can give early information for researcher, doctor and other practical that can be used as reference to continue the research as well as to give scientific. CHS (Cancer Herbal Screening) part is design plasmid which contain  promoter P97 (HPV 16) or P105 (HPV 18). This part has ability in screening chemical compounds of plant for cervical cancer therapy. The herbs have to inhibit transcription factor of P97 and P10. <br><br>
 +
 
 +
Promoter was combained with fluorescence reporter GFP obtained from biobrick Bba_E0240 (Plate 4, well 11N) to detect the successfull of the herbal compounds.  P97 (HPV 16) and P105 (HPV 18) were digested with EcoR1-Xbal, GFP digested with Xbal-Pstl, and plasmid backbone pSB1C3 digested with EcoR1-Pstl. Then, the HPV promoter and GFP was ligated into palsmid backbone pSB1C3. Plasmid design was transfected into HeLa cells containing some transcripton factor to induced promoter. Based on Chong et al (1991), trancript factor such as NF1, AP-1, and oct-1 were present in higher concentration in HeLa cells. Therefor, HeLa cells can be used as transfection for promoter P97 and promoter P105 so it could be activated. This part was purposed to help researcher work easier to explore herbal plants for cervical cancer therapy.</p> <br><br>
 +
 
 +
<center><img src="https://static.igem.org/mediawiki/2014/e/ef/UB-overview_therapy.PNG" width="500" height="300"><br>
 +
Figure 1. Construction of CHS (Cancer Herbal Screening) in pSB1C3
 +
</center> 
 +
 
 +
<p align="justify">
 +
<b>References :</b><br>
 +
<ul>
 +
<li>Bernard, B. A., C. Bailly, M.-C. Lenoir, M. Darmon, F. Thierry, and M. Yaniv. 1989. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol  63:4317-4324.</li>
 +
<li>Braunstein TH, BS Madsen, B Gavnholt, MW Rosenstierne, C Koefoed Johnsen and B norrild. 1999. Identification of a new promoter in the early region of the human papillomaviruses type 16 genome. Journal of General Virology 80: 3241-3250</li>
 +
<li>Chong, T., D. Apt, B. Gloss, M. Isa, and H. U. Bernard. 1991. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors Oct-1, NFA, TEF-2, NF1, and AP1 participate in epithelial cell-specific transcription. J. Virol. 65:5933–5943. </li>
 +
<li>Das, B.C. 2003. Cellular control of human papillomavirus gene activity in cervical cancer. Proc.Indian natn Sci Acan. B69 No.1 pp23-24. </li>
 +
<li>Dell, G., and K. Gaston. 2001. Contributions in the domain of cancer research:review of human papillomaviruses and their role in cervical cancer.Cell. Mol. Life Sci.58:1923–1942. </li>
 +
<li>Flores, E. R., and P. F. Lambert. 1997. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J. Virol. 71:7167–7179. </li>
 +
<li>Frazer, I. H., J. T. Cox, et al. 2006. Advances in prevention of cervical cancer and other human papillomavirus-related diseases.Pediatr Infect Dis J 25(2 Suppl): S65-81, quiz S82. </li>
 +
<li>Hebner, C. M., and L. A. Laimins. 2006. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol16:83–97. </li>
 +
<li>Laura Sichero, Eduardo Luis Franco, and Luisa Lina Villa. 2005. Different P105 Promoter Activities among Natural Variants of Human Papillomavirus Type 18. The Journal of Infectious Diseases191:739–42. </li>
 +
<li>Lowy, D. R. and J. T. Schiller. 2006. Prophylactic human papillomavirus vaccines. J Clin Invest 116(5): 1167-73. </li>
 +
<li>Martinez., AS Gardiner, KF Board, FA Monzon, RP Edwards and SA Khan. 2008. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27:2575-2582</li>
 +
<li>Romanczuk H., F Thierry and P M Howley. 1990.Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol64(6):2849. </li>
 +
<li>Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. International journal of cancer121:621-32. </li>
 +
<li>Song, Shiyu., Amy Liem, James A., Miller and Paul F Lambert. 2000. Human Papillomavirus Types 16 E6 and E7 Contribute Differently to Carcinogenesis. Virology 267:141-150. </li>
 +
<li>Thierry, F., and M. Yaniv. 1987. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV 18 regulatory region. EMBO J6:3391-3397. </li>
 +
<li>Thierry, F., J. M. Heard, K. Dartmann, and M. Yaniv. 1987. Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J. Virol61:134-142. </li>
 +
</ul>
</p>
</p>
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Therapy</font></h2>
<h2 class="font-thin"><font color="#fff">Therapy</font></h2>
</div><!-- /col12 -->
</div><!-- /col12 -->
 +
</div><!-- /row -->
</div><!-- /row -->
</div><!-- /container -->
</div><!-- /container -->
Line 265: Line 403:
<div class="row line-row">
<div class="row line-row">
<div class="hr">&nbsp;</div>
<div class="hr">&nbsp;</div>
 +
</div><!-- /row -->
 +
<div class="row subtitle-row">
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
 +
<div class="col-12 col-sm-10 font-light">&nbsp;</div>
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
</div><!-- /row -->
</div><!-- /row -->
<div class="row content-row">
<div class="row content-row">
Line 273: Line 416:
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Timeline</font></h2>
<h2 class="font-thin"><font color="#fff">Timeline</font></h2>
 +
                                        <h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
Line 278: Line 422:
<a href="#lab-journal" class="fancybox"><p><i class="icon icon-book"></i></p></a>
<a href="#lab-journal" class="fancybox"><p><i class="icon icon-book"></i></p></a>
                                         <div id="lab-journal" style="display:none;width:700px;">
                                         <div id="lab-journal" style="display:none;width:700px;">
-
<h2><center>“LAB JOURNAL”</center></h2>
+
<h2><center>LAB JOURNAL</center></h2>
<p align="justify">
<p align="justify">
<ul type="circle">
<ul type="circle">
Line 344: Line 488:
<ul>
<ul>
<li>Week 1</li>
<li>Week 1</li>
-
Splitting HeLa cells. The confluence HeLa cells (80 – 90%) splitting into another flask then incubate in 37ᵒC.
+
Splitting HeLa cells. The confluence HeLa cells (80 – 90%) splitting into another flask then incubate in 37ᵒC.<br>
 +
<center>https://static.igem.org/mediawiki/2014/0/0f/UB-HELA.jpg</center>
<li>Week 2</li>
<li>Week 2</li>
Cell observation. The splitting HeLa cells observed to control the growth.
Cell observation. The splitting HeLa cells observed to control the growth.
Line 384: Line 529:
Figure 4. There are two TALES we tried to synthesize, TALE 1 and TALE 2. Every TALE has triplo but only T1-2, T2-1, and T2-2 succesfully assembled.</center><br>
Figure 4. There are two TALES we tried to synthesize, TALE 1 and TALE 2. Every TALE has triplo but only T1-2, T2-1, and T2-2 succesfully assembled.</center><br>
<p align="justify">
<p align="justify">
-
We collected as many as possible references for the application content. Our application is android mobile based and we started to encode it. The application consist of preventing and therapy suggestion also screening method information. Special feature from our application is snap tool that can detect the kit result.
+
We collected as many as possible references for the application content. Our application is android mobile based and we started to encode it. The application consist of preventing and therapy suggestion also screening method information. Special feature from our application is snap tool that can detect the kit result.<br><br>
 +
 
 +
<b>July Week 1– August</b><br>
 +
<table width="100%">
 +
<tr><td>Discussion about the material and tool which complete the task of the devices. We  looked for some well known, user friendly, easy handle, effective, and efficient. We also get some material recommendation and suggestion for our device. Then, by some review and consideration, we decided to use a test pack for the tool (hardware) and colour intensity as the diagnostic result.</td>
 +
<td><img src="https://static.igem.org/mediawiki/2014/4/49/Ub-Test_pack_1.jpg" width="400" height="200"></td></tr>
 +
 
 +
</table><br>
 +
 
 +
<b>August 4th – August 8th (Week 2)</b><br>
 +
<table width="100%">
 +
<tr><td><img src="https://static.igem.org/mediawiki/2014/5/56/UB-Test_pack_2.jpg" width="400" height="150"></td>
 +
<td>Chose and bought some test pack to be learned. Here, we got some model of test pack to study and determine the model from one of common trademark as the basic model of ours.</td></tr>
 +
</table><br>
 +
 
 +
<b>September 8th – September 12th  (Week 2)</b><br>
 +
We try to put the enzyme into model and observed the result. We performed some test in different variable to determine its reliability.<br>
 +
<table width="100%">
 +
<tr><td align="right"><img src="https://static.igem.org/mediawiki/2014/d/db/UB-TP_1.jpg" width="300" height="100"></td>
 +
<td><img src="https://static.igem.org/mediawiki/2014/8/8c/UB-TP_2.jpg" width="300" height="100"></td></tr>
 +
<tr><td align="right"><img src="https://static.igem.org/mediawiki/2014/0/02/UB-TP_3.jpg" width="300" height="100"></td>
 +
<td><img src="https://static.igem.org/mediawiki/2014/7/77/UB-TP_4.jpg" width="300" height="100"></td></tr>
 +
</table><br>
 +
 
 +
<b>September 15th – September 19th (Week 3)</b><br>
 +
Still continue to test the device and get more result.<br><br>
 +
 
 +
<b>September 22nd – September 26th (Week 4)</b><br>
 +
Get some suggestion and more explanation from our lecturer in Biology about the result <br><br>
 +
 
 +
<b>September 29th – October 3rd </b><br>
 +
Performed stability test to know more about the device. We even did it with a little various differentiation.<br><br>
 +
 
 +
<b>October 2th – October 5th  (Week 1)</b><br>
 +
We designed the software content and review it from some journals and articles.<br>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2014/c/cf/Ub-software1.jpg" width="300" height="500"><br><br>
 +
<img src="https://static.igem.org/mediawiki/2014/1/1e/Ub-software2.jpg" width="300" height="500"><br><br>
 +
<img src="https://static.igem.org/mediawiki/2014/d/da/Ub-software3.jpg" width="300" height="500"><br><br>
 +
<img src="https://static.igem.org/mediawiki/2014/4/41/Ub-software4.jpg" width="300" height="500"><br><br>
 +
<img src="https://static.igem.org/mediawiki/2014/c/c9/Ub-software5.jpg" width="300" height="500"><br><br>
 +
</center>
 +
 
 +
<b>October 6th – October 10th  (Week 2)</b><br>
 +
Collected the results and put it into results table to be presented.<br>
 +
We try to develop the software with ECLIPSE program .<br><br>
</p>
</p>
</ul>
</ul>
Line 390: Line 580:
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Lab Journal</font></h2>
<h2 class="font-thin"><font color="#fff">Lab Journal</font></h2>
 +
<h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
<a href="#protocols" class="fancybox"><p><i class="icon icon-tasks"></i></p></a>
<a href="#protocols" class="fancybox"><p><i class="icon icon-tasks"></i></p></a>
                                         <div id="protocols" style="display:none;width:700px;">
                                         <div id="protocols" style="display:none;width:700px;">
-
<h2><center>“PROTOCOLS”</center></h2>
+
<h2><center>PROTOCOLS</center></h2>
<p align="justify">
<p align="justify">
<b>P97 and P105 digestion. </b>
<b>P97 and P105 digestion. </b>
Line 595: Line 786:
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Protocols</font></h2>
<h2 class="font-thin"><font color="#fff">Protocols</font></h2>
 +
<h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-sm-1 hidden-sm">&nbsp;</div>
<div class="col-sm-1 hidden-sm">&nbsp;</div>
Line 610: Line 802:
<div class="row line-row">
<div class="row line-row">
<div class="hr">&nbsp;</div>
<div class="hr">&nbsp;</div>
 +
</div><!-- /row -->
 +
<div class="row subtitle-row">
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
 +
<div class="col-12 col-sm-10 font-light"></div>
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
</div><!-- /row -->
</div><!-- /row -->
<div class="row content-row">
<div class="row content-row">
Line 615: Line 812:
<a href="#workshop" class="fancybox"><p><i class="icon icon-link"></i></p></a>
<a href="#workshop" class="fancybox"><p><i class="icon icon-link"></i></p></a>
                                         <div id="workshop" style="display:none;width:700px;">
                                         <div id="workshop" style="display:none;width:700px;">
-
<h2><center>“Early Step for Synthetic Biology Development in Indonesia”</center></h2>
+
<h2><center>Early Step for Synthetic Biology Development in Indonesia</center></h2>
<p align="justify">
<p align="justify">
iGEM is not only a competition which provides a stage for us to perform our work done at the laboratory but also an effort to popularize synthetic biology to the public. Synthetic biology is not popular yet in Indonesia and there are many people who do not know about this field. Therefore we decided to hold a workshop entitled “Potential and applications of synthetic biology in Indonesia” which was held on September, 26th - 27th 2014.<br><br>
iGEM is not only a competition which provides a stage for us to perform our work done at the laboratory but also an effort to popularize synthetic biology to the public. Synthetic biology is not popular yet in Indonesia and there are many people who do not know about this field. Therefore we decided to hold a workshop entitled “Potential and applications of synthetic biology in Indonesia” which was held on September, 26th - 27th 2014.<br><br>
ITB iGEM team and UI iGEM team also took part in our activities and make it more fun. The participants not just come from undergraduate student but also from postgraduate student from various university in Indonesia. We got that audience are so enthusiastic through our lecture. The lecture has five parts, including introduction of synthetic biology and its potential for immunology therapy, potential of biology synthetic for health and medicine field, introduction about iGEM, presentation material from ITB iGEM team, project of syntetic biology community of UGM, and presentation material from iGEM-UB.<br><br>
ITB iGEM team and UI iGEM team also took part in our activities and make it more fun. The participants not just come from undergraduate student but also from postgraduate student from various university in Indonesia. We got that audience are so enthusiastic through our lecture. The lecture has five parts, including introduction of synthetic biology and its potential for immunology therapy, potential of biology synthetic for health and medicine field, introduction about iGEM, presentation material from ITB iGEM team, project of syntetic biology community of UGM, and presentation material from iGEM-UB.<br><br>
Synthetic biology is a newly-developing subject. We hope through our event there will be a better understanding about what synthetic biology is, its potential and encouraged people to develop synthetic biology in Indonesia. Beside, we held a workshop about bioinformatics. Why we choose bioinformatics? Because it is needed for molecule prediction before we do some molecular work at laboratory. It also useful and be a basic for developing synthetic biology. Thanks to Synbio community from Gadjah Mada University and student from University State of Malang who took part on our workshop.<br><br>
Synthetic biology is a newly-developing subject. We hope through our event there will be a better understanding about what synthetic biology is, its potential and encouraged people to develop synthetic biology in Indonesia. Beside, we held a workshop about bioinformatics. Why we choose bioinformatics? Because it is needed for molecule prediction before we do some molecular work at laboratory. It also useful and be a basic for developing synthetic biology. Thanks to Synbio community from Gadjah Mada University and student from University State of Malang who took part on our workshop.<br><br>
-
Well, hopefully this small step can be the beginning of a big step in the world of synthetic biology in Indonesia. Such as a cell that will develop into tissues and has a function. Go synthetic biology!
+
Well, hopefully this small step can be the beginning of a big step in the world of synthetic biology in Indonesia. Such as a cell that will develop into tissues and has a function. Go synthetic biology! <br><br>
</p>
</p>
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Workshop</font></h2>
<h2 class="font-thin"><font color="#fff">Workshop</font></h2>
 +
                                        <h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
Line 629: Line 827:
<a href="#education" class="fancybox"><p><i class="icon icon-pencil"></i></p></a>
<a href="#education" class="fancybox"><p><i class="icon icon-pencil"></i></p></a>
                                         <div id="education" style="display:none;width:700px;">
                                         <div id="education" style="display:none;width:700px;">
-
<h2><center>“Say Hi to Young Scientist Wannabe!</center></h2>
+
<h2><center>Say Hi to Young Scientist Wannabe!</center></h2>
<p align="justify">
<p align="justify">
Synthetic Biology (Synbio) can not stop on our generation, but must be passed on the generations below us. Therefore, we hold socialization Synbio to students high school in Malang, East Java, Indonesia. Our focus is opening their minds to the real world’s problem and things we can do through science and engineering. We presented it by video animation, power point and brochure. <br><br>
Synthetic Biology (Synbio) can not stop on our generation, but must be passed on the generations below us. Therefore, we hold socialization Synbio to students high school in Malang, East Java, Indonesia. Our focus is opening their minds to the real world’s problem and things we can do through science and engineering. We presented it by video animation, power point and brochure. <br><br>
-
We hold imaginationclasses, in which students were divided into groups and given the opportunity toimagine bio-machine that can solve the problems in the world. Wow! The results were shocking! They have wild imagination in implantingsynbio concept clearly and precisely. Well, although some ideas seem impossible, but hey, there is nothing impossible in science, isn’t it?</p>
+
We hold imagination classes, in which students were divided into groups and given the opportunity toimagine bio-machine that can solve the problems in the world. Wow! The results were shocking! They have wild imagination in implantingsynbio concept clearly and precisely. Well, although some ideas seem impossible, but hey, there is nothing impossible in science, isn’t it?<br><br>
 +
 
 +
<b>BACKGROUND</b><br>
 +
Human practice is socialization activity that involving the public into the future of synthetic biology. Thus, synthetic biology as one kind of science field have great potency and implications to improve lives by solving problems. iGEM Team Brawijaya dveloping the human practice activity through school education program and social education program. The school education purpose to introduce the synthetic biology for student then social education purpose to introducing for public. Moreover, we also presenting our project of iGEM Team Brawijaya through presentation and discussion. <br><br>
 +
 
 +
<b>DESCRIPTION</b><br>
 +
School education program within Human Practice be held on senior high school in malang. Thats program begin with presentation about synthetic biology. Presenter explain about overview and synthetic biology application in many kind of field. The presentation also added with animation video to more attractive and make the materi easily to be comprehended. Then, the presentation continued with presentation about project of iGEM Team Brawijaya as an example of synthetic biology application in health field. We make discussion, allowing students to ask some question and everything that they want to know. So, we can dig up and share more knowledge about synthetic biology. <br>
 +
 
 +
The program continued with creativity games. All of student in the class divided into 4 groups that each group contains of 8 students. Presenter was explain about some cases involving synthetic biology. Then, each group allowed to take discussion, case study and solve the problem. After that, each group also allowed to find some problems around them and have to solve the problems using synthetic biology. Result of discussion froum each group presented in front of the class. We can conclude that each group have some of great creativity and big imagine about synthetic biology. We think that is great future
 +
</p>
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Education</font></h2>
<h2 class="font-thin"><font color="#fff">Education</font></h2>
-
+
<h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
<a href="#society" class="fancybox"><p><i class="icon icon-group"></i></p></a>
<a href="#society" class="fancybox"><p><i class="icon icon-group"></i></p></a>
                                         <div id="society" style="display:none;width:700px;">
                                         <div id="society" style="display:none;width:700px;">
-
<h2><center>“From Lab For Society”</center></h2>
+
<h2><center>From Lab For Society</center></h2>
<p align="justify">
<p align="justify">
Doing research and explore a new thing which will be useful for society is really important, but, the other thing that also important is the socialization to society. So, we bring synthetic biology to solve society’s problem.<br><br>
Doing research and explore a new thing which will be useful for society is really important, but, the other thing that also important is the socialization to society. So, we bring synthetic biology to solve society’s problem.<br><br>
Line 650: Line 857:
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Society</font></h2>
<h2 class="font-thin"><font color="#fff">Society</font></h2>
-
+
<h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-sm-1 hidden-sm">&nbsp;</div>
<div class="col-sm-1 hidden-sm">&nbsp;</div>
Line 665: Line 872:
<div class="row line-row">
<div class="row line-row">
<div class="hr">&nbsp;</div>
<div class="hr">&nbsp;</div>
 +
</div><!-- /row -->
 +
<div class="row subtitle-row">
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
 +
<div class="col-12 col-sm-10 font-light"></div>
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
</div><!-- /row -->
</div><!-- /row -->
<div class="row content-row">
<div class="row content-row">
Line 673: Line 885:
<a href="#collaboration" class="fancybox"><p><i class="icon icon-group"></i></p></a>
<a href="#collaboration" class="fancybox"><p><i class="icon icon-group"></i></p></a>
                                         <div id="collaboration" style="display:none;width:700px;">
                                         <div id="collaboration" style="display:none;width:700px;">
-
<h2><center>“Let’s Meet Up!</center></h2>
+
<h2><center>Let’s Meet Up!</center></h2>
<p align="justify">UB iGEM Team had collaboration with UI iGEM Team and ITB iGEM team in holding Synthetic Biology for Indonesia Community. The aim of this community is to form a synthetic biology  association in Indonesia.Programs that have been done previously is an online course in facebook group named “Synthetic Biology for Indonesia” and already got approximately 121 members from all over Indonesia.<br><br>
<p align="justify">UB iGEM Team had collaboration with UI iGEM Team and ITB iGEM team in holding Synthetic Biology for Indonesia Community. The aim of this community is to form a synthetic biology  association in Indonesia.Programs that have been done previously is an online course in facebook group named “Synthetic Biology for Indonesia” and already got approximately 121 members from all over Indonesia.<br><br>
For developing this community, we conducted a forum for us to meet up with others synbio community all over Indonesia. This forum (meet up) was initiated by UB iGEM Team, ITB iGEM Team and UI iGEM Team. For this year, 2014, the meeting was held in Brawijaya University, Malang, East Java, Indonesia on September, 27th 2014. The event combined with seminar and workshop in synthetic biology. We also invited synthetic biology community of Gadjah Mada University, synthetic biology community of Sumbawa Technology University, Biology department of Airlangga University and Biology department of State of Malang University.<br><br>
For developing this community, we conducted a forum for us to meet up with others synbio community all over Indonesia. This forum (meet up) was initiated by UB iGEM Team, ITB iGEM Team and UI iGEM Team. For this year, 2014, the meeting was held in Brawijaya University, Malang, East Java, Indonesia on September, 27th 2014. The event combined with seminar and workshop in synthetic biology. We also invited synthetic biology community of Gadjah Mada University, synthetic biology community of Sumbawa Technology University, Biology department of Airlangga University and Biology department of State of Malang University.<br><br>
-
We tend to do annual meet up for discussing anything about synthetic biology, start from research until social action. In the other hand, each of the university member will link together to be strengthen community and cooperate with government, practitioners and scientist in Indonesia.</p>
+
We tend to do annual meet up for discussing anything about synthetic biology, start from research until social action. In the other hand, each of the university member will link together to be strengthen community and cooperate with government, practitioners and scientist in Indonesia.</p><br><br>
 +
<b>Collaboration part with ITB teams are some cloned parts :</b><br>
 +
<ul>
 +
<li> Syntethic sequence (P97 and P105) inserted into plasmid pJET.</li>
 +
<li> GFP reporter in plate 4 well 11N inserted into plasmid PSB1A3 with Ampicillin resistance.</li>
 +
<li> Promoter CMV in plate 1 well 21P inserted into PSB1C3 with chloramphenicol resistance.</li>
 +
</ul>
 +
"We acknowledge to all members of IGEM ITB team for helping us doing of parts project."<br><br>
 +
 
 +
For developing TALE 1 and TALE 2, we've got the material- GATE Assembly Kit, pTALEN and pTAL-TF -from BIOSS at University of Freiburg by Nicole Gensch. <br>
 +
<img src="https://static.igem.org/mediawiki/2014/d/dd/UB-Bioss.jpg" height="200" width="400">
 +
 
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">SYNBIO FOR INDONESIA</font></h2>
<h2 class="font-thin"><font color="#fff">SYNBIO FOR INDONESIA</font></h2>
-
+
<h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
Line 697: Line 920:
<div class="row line-row">
<div class="row line-row">
<div class="hr">&nbsp;</div>
<div class="hr">&nbsp;</div>
 +
</div><!-- /row -->
 +
<div class="row subtitle-row">
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
 +
<div class="col-12 col-sm-10 font-light"></div>
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
</div><!-- /row -->
</div><!-- /row -->
<div class="row content-row">
<div class="row content-row">
Line 702: Line 930:
<a href="#sub-parts" class="fancybox"><p><i class="icon icon-link"></i></p></a>
<a href="#sub-parts" class="fancybox"><p><i class="icon icon-link"></i></p></a>
                                         <div id="sub-parts" style="display:none;width:700px;">
                                         <div id="sub-parts" style="display:none;width:700px;">
-
<h2><center>“Submited Parts”</center></h2>
+
<h2><center>Submited Parts</center></h2>
<ul type="circle">
<ul type="circle">
<li>Therapy</li>
<li>Therapy</li>
Line 718: Line 946:
<br><br>
<br><br>
<b>Preventing and Therapy Team Safety</b>
<b>Preventing and Therapy Team Safety</b>
-
<center><table border="1">
+
<table border="1">
<tr><th>Part Number</th><th>DNA Source</th><th>Species Origin</th><th>Species Risk Group</th><th>Part Function</th></tr>
<tr><th>Part Number</th><th>DNA Source</th><th>Species Origin</th><th>Species Risk Group</th><th>Part Function</th></tr>
-
<tr><td>Bba_K747096</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>CMV Promoter</td></tr>
+
<tr><td>Bba_K747096</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>CMV Promoter</td></tr>
-
<tr><td>Bba_E0240</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>GFP Generator</td></tr>
+
<tr><td>Bba_E0240</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>GFP Generator</td></tr>
-
<tr><td>Bba_K516132</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Constitutive promoter with mRFP, RBS B0032</td></tr>
+
<tr><td>Bba_K516132</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Constitutive promoter with mRFP, RBS B0032</td></tr>
-
<tr><td>pTALEN</td><td>From BIOSS in University of Freiburg, Germany</td><td>Xanthomonas spp.</td><td>2</td><td>Vector</td></tr>
+
<tr><td>pTALEN</td><td>From BIOSS in University of Freiburg, Germany</td><td>Xanthomonas spp.</td><td align="center">2</td><td>Vector</td></tr>
-
<tr><td>pTAL-TF</td><td>From BIOSS in University of Freiburg, Germany</td><td>Xanthomonas spp.</td><td>2</td><td>Vector</td></tr>
+
<tr><td>pTAL-TF</td><td>From BIOSS in University of Freiburg, Germany</td><td>Xanthomonas spp.</td><td align="center">2</td><td>Vector</td></tr>
-
<tr><td>p97 promoter</td><td>Synthesized by IDT</td><td>HPV type 16</td><td>2</td><td>Cell Line</td></tr>
+
<tr><td>P97 Promoter</td><td>Synthesized by IDT</td><td>HPV type 16</td><td align="center">2</td><td>Cell Line</td></tr>
-
<tr><td>p105 promoter</td><td>Synthesized by IDT</td><td>HPV type 16</td><td>2</td><td>Cell Line</td></tr>
+
<tr><td>P105 Promoter</td><td>Synthesized by IDT</td><td>HPV type 18</td><td align="center">2</td><td>Cell Line</td></tr>
</table>
</table>
<br><br>
<br><br>
 +
<b>Screening Team Safety</b>
<table border="1">
<table border="1">
<tr><th>Part Number</th><th>DNA Source</th><th>Species Origin</th><th>Species Risk Group</th><th>Part Function</th></tr>
<tr><th>Part Number</th><th>DNA Source</th><th>Species Origin</th><th>Species Risk Group</th><th>Part Function</th></tr>
-
<tr><td>Bba_K747012</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747012</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747016</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747016</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747042</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747042</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747048</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747048</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747064</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747064</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747091</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747091</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747012</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747012</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747026</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747026</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747036</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747036</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747052</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747052</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747076</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747076</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747095</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Protein Domain </td></tr>
+
<tr><td>Bba_K747095</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Protein Domain </td></tr>
-
<tr><td>Bba_K747101</td><td>Part registry</td><td>E. coli DH5α</td><td>1</td><td>Plasmid </td></tr>
+
<tr><td>Bba_K747101</td><td>Part registry</td><td>E. coli DH5α</td><td align="center">1</td><td>Plasmid </td></tr>
</table>
</table>
-
</center>
+
 
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Submitted Parts</font></h2>
<h2 class="font-thin"><font color="#fff">Submitted Parts</font></h2>
-
+
<h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
Line 757: Line 986:
<a href="#fav-parts" class="fancybox"><p><i class="icon icon-group"></i></p></a>
<a href="#fav-parts" class="fancybox"><p><i class="icon icon-group"></i></p></a>
                                         <div id="fav-parts" style="display:none;width:700px;">
                                         <div id="fav-parts" style="display:none;width:700px;">
-
<h2><center>“”</center></h2>
+
<h2><center>Favorite Parts</center></h2><br>
-
<p align="justify"></p>
+
<a href="http://parts.igem.org/Part:BBa_E0240:Design"><b>Bba_E0240 GFP_Generator </b></a><br><br>
 +
<center>
 +
<img src="https://static.igem.org/mediawiki/2014/0/0b/UB-GFP_1.PNG" width="200" height="100"><br>
 +
<img src="https://static.igem.org/mediawiki/2014/d/d9/UB-GFP-PLASMID_2.PNG" width="500" height="500"></center><br><br>
 +
 
 +
<a href="http://parts.igem.org/Part:BBa_K747012"><b>Bba_K747012 TALE_Protein_TA1_Direpeat </b></a><br><br>
 +
<center><img src="https://static.igem.org/mediawiki/2014/9/9b/UB-TALE-PLASMID_2.PNG" width="500" height="500"></center>
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Favorite Parts</font></h2>
<h2 class="font-thin"><font color="#fff">Favorite Parts</font></h2>
-
 
+
                                        <h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-sm-1 hidden-sm">&nbsp;</div>
<div class="col-sm-1 hidden-sm">&nbsp;</div>
Line 794: Line 1,029:
<div class="row line-row">
<div class="row line-row">
<div class="hr">&nbsp;</div>
<div class="hr">&nbsp;</div>
 +
</div><!-- /row -->
 +
<div class="row subtitle-row">
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
 +
<div class="col-12 col-sm-10 font-light"></div>
 +
<div class="col-sm-1 hidden-sm">&nbsp;</div>
</div><!-- /row -->
</div><!-- /row -->
<div class="row content-row">
<div class="row content-row">
Line 904: Line 1,144:
</script>
</script>
<h2 class="font-thin"><font color="#fff">Members</font></h2>
<h2 class="font-thin"><font color="#fff">Members</font></h2>
 +
                                        <h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
+
<a href="#testimoni" class="fancybox"><p><i class="icon icon-comment"></i></p></a>
 +
                                        <div id="testimoni" style="display:none;width:700px;">
 +
<h2>What People Says About iGEM UB ?</h2><br>
 +
<ul>
 +
<li><b>GAMANANTA Support UB iGEM Team 2014</b></li><br>
 +
<center><img src="https://static.igem.org/mediawiki/2014/0/0f/UB-GAMANANTA.jpg" width="500" height="200"></center><br>
 +
<p align="justify">
 +
When i was a child, i’m educated by my parents about the importance of healthiness. Because we believe that healthiness is expensive. Therefore, eventhough we can not avoid sickness, prevention action is better than curing. Especially disease that spread by HPV virus on cervical cancer which generally attacks women. Men can also suffered from this disease.<br><br>
 +
Seeing the description of the outline of project brought by the IGEM team Biology FMIPA at UB, I become understand how important their steps. The program brings the C3P (Cervical Cancer Care - Preventing, Screening, Treatment) that are currently in progress of development, IGEM team Biology FMIPA offers a real solution on prevention of cervical cancer at early stages. A solution with a very good prospect. Shows the path of the light that prevention is indeed better.<br><br>
 +
For me personally, with GAMANANTA friends as travelling community that loves to have a trip, fully support that program. I openly invite friends to not underestimate cervical cancer because its deadly impact. We often underestimate influenza that can disturb our trip. It will not very sad if our dream travel to various quarters of destination both domestic and foreign disturbed by the presence of a virus diseases might threaten at any time.<br><br>
 +
I hope, among IGEM team Biology FMIPA UB and their program objectives could have a positive relation. Thus, it feel easier if both components work together. Awareness program objectives are not easily changed, but does not mean impossible. And C3P development program is one solutive step to increase awareness of program objectives . Time to beat the "drums of war" against cervical cancer and together achieve a better future.<br><br></p>
 +
<p align="left">Warm regards,<br>
 +
<b>Rifqy Faiza Rahman<br>
 +
Founder & Commissioner of GAMANANTA</b></p><br><br>
 +
 
 +
<li><b>YPKAI Support UB iGEM Team 2014</b></li><br>
 +
<center><img src="https://static.igem.org/mediawiki/2014/e/e3/UB-YPKAI.jpg" width="500" height="200"></center><br>
 +
<p align="justify">"Salute to UB team for the attention and care in cervical cancer, especially this cancer increasingly higher numbers of sufferers. Hopefully the research can have a positive effect in reducing the risk and treatment of cancer, as well as support the careness of cancer risk which threaten anyone from amongst any and all ages. Hopefully the results of this work can also inspire young people of Indonesia to continue to work for the nation and each other."</p><br><br>
 +
<p align="left">Warm regards,<br>
 +
<b>Indonesia Child Cancer Care (YPKAI)<br>
 +
Together reaching hope for kid with cancer</b></p>
 +
</ul>
 +
                                        </div>
 +
<h2 class="font-thin"><font color="#fff">People Says</font></h2>
 +
                                        <h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
Line 914: Line 1,179:
                                         </div>
                                         </div>
<h2 class="font-thin"><font color="#fff">Sponsors</font></h2>
<h2 class="font-thin"><font color="#fff">Sponsors</font></h2>
 +
                                        <h4 class="font-thin"><font color="#fff"></font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-sm-1 hidden-sm">&nbsp;</div>
<div class="col-sm-1 hidden-sm">&nbsp;</div>

Latest revision as of 01:15, 18 October 2014

iGEM2014 | UB INDONESIA

BRAWIJAYA UNIVERSITY , INDONESIA

This is team wiki to share our iGEM experience



iGEM UB
BRAWIJAYA UNIVERSITY
iGEM2014
PROJECT
 

Background

Overview

Achievement

Preventing

Screening

Therapy

NOTEBOOK
 
 

Timeline

Lab Journal

Protocols

HUMAN PRACTICE
 

Workshop

Education

Society

COLLABORATIONS
 

SYNBIO FOR INDONESIA

PARTS
 

Submitted Parts

ABOUT US
 

Members

People Says

Sponsors

Leave us a message
 
You can find us literally anywhere,

just push a button and we’re there

in/igemub

igemub@gmail.com

Malang, Indonesia
zip code 65145

facebook/igembrawijaya

@igem_ub